通气异质性与强迫振荡预测未控制哮喘升级吸入治疗后的控制改善
本研究纳入19例未控制哮喘患者(ACQ5>1.5,每日氟替卡松等效剂量≤500 μg),予氟替卡松/福莫特罗250/10 μg每日两次、每次两吸治疗8周,评估外周气道功能与症状改善的关系。治疗后ACQ5、FEV1、FVC、FeNO、Xrs5Hz及MBNW指标均改善;基线LCI、Scond和Rrs5Hz可预测ACQ5改善,基线Scond对临床意义改善(ΔACQ>0.5)预测最佳(ROC-AUC=0.91,P=0.007)。
要点
- 基线MBNW与强迫振荡参数可预测升级治疗后的哮喘控制改善
- 基线Scond对ΔACQ>0.5的预测ROC-AUC达0.91
- 升级治疗后外周气道功能(Xrs5Hz、MBNW)随症状同步改善
核心结论
- 未控制哮喘升级至高剂量ICS/LABA后外周气道功能改善,基线MBNW与强迫振荡参数可预测症状改善。
研究设计与样本
- 前瞻性研究,19例未控制哮喘患者(14例女性,平均年龄29.9±13.6岁),治疗前后各测量一次。
主要发现
- 治疗8周后ACQ5(P=0.0002)、FEV1(P=0.02)、FVC(P=0.04)、FeNO(P=0.0008)、Xrs5Hz(P=0.01)、LCI(P=0.0002)、Sacin(P=0.006)、Scond(P=0.01)均改善。
- 基线ACQ5与Xrs5Hz相关(rs=0.52,P=0.03),与Rrs5Hz相关(rs=0.55,P=0.02)。
- ACQ5改善可由基线LCI更异常(P=0.03)、Scond(P=0.02)、Rrs5Hz(P=0.006)预测。
- 基线Scond是临床意义改善(ΔACQ>0.5)的最佳预测指标(ROC-AUC=0.91,P=0.007)。
关键数值与推荐
- 未控制哮喘定义:ACQ5>1.5,且每日氟替卡松等效剂量≤500 μg。
- 治疗方案:氟替卡松/福莫特罗250/10 μg,每次两吸、每日两次,共8周。
- 临床意义改善阈值:ΔACQ>0.5。
临床怎么用
- 对未控制哮喘患者,可考虑以基线Scond、LCI、Rrs5Hz辅助识别升级吸入治疗的可能获益者。
局限性
- 样本量仅19例,结果需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Abnormal peripheral airway function is an important feature of asthma and relates to asthma symptoms and poor asthma control. We aimed to determine whether peripheral airway function, as measured by forced oscillatory impedance and multiple-breath nitrogen washout (MBNW), relates to symptom improvement in asthmatic participants with uncontrolled asthma, after stepping up to high-dose ICS/LABA treatment. METHODS: A total of 19 subjects (14 females, mean age: 29.9 ± 13.6 years) with uncontrolled asthma, as defined by an ACQ5 > 1.5, taking 500 μg/day fluticasone equivalent or less, underwent spirometry, plethysmography, fractional exhaled FeNO, forced oscillatory resistance (Rrs5Hz ) and reactance (Xrs5Hz ), and indices of MBNW ventilation heterogeneity (lung clearance index (LCI), diffusion-convection-dependent (Sacin) and convection-dependent (Scond)). Measurements were made before and after 8 weeks of treatment with fluticasone/formoterol combination inhaler 250/10 μg, 2 puffs twice daily. RESULTS: Treatment improved ACQ5 (P = 0.0002), FEV1 (P = 0.02), FVC (P = 0.04), FeNO (P = 0.0008), Xrs5Hz (P = 0.01), LCI (P = 0.0002), Sacin (P = 0.006) and Scond (P = 0.01). At baseline, ACQ5 correlated with Xrs5Hz (rs = 0.52, P = 0.03) and Rrs5Hz (rs = 0.55, P = 0.02). The improvement in ACQ5 was predicted by more abnormal baseline LCI (P = 0.03), Scond (P = 0.02) and Rrs5Hz (P = 0.006). Baseline Scond was the best predictor of a clinically meaningful improvement in asthma control (ΔACQ > 0.5, ROC-AUC = 0.91, P = 0.007). CONCLUSION: Step-up to high-dose combination treatment in uncontrolled asthma is associated with improved peripheral airway function as measured by Xrs5Hz and MBNW. Baseline MBNW and FOT parameters correlated with the improvement in symptoms and may predict a positive response to up-titration in uncontrolled asthmatic patients.
引用
- Tang FSM, Rutting S, Farrow CE, et al. Ventilation heterogeneity and oscillometry predict asthma control improvement following step-up inhaled therapy in uncontrolled asthma. Respirology. 2020. PMID: 32026586. doi:10.1111/resp.13772
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。